USPTO serial 77196079
OXITRAN
Reviewed by CopyMark Law Group
Reg. 3730389Status 710
- Filing date
- Status date
- Registration date
- Dec 29, 2009
- Examiner
- MCCAULEY, BRENDAN D
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with OXITRAN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Santhera Pharmaceuticals (Schweiz) AG
Liestal, CH
Other trademarks owned by Santhera Pharmaceuticals (Schweiz) AG
Santhera Pharmaceuticals (Schweiz) AG
Liestal, CH
Other trademarks owned by Santhera Pharmaceuticals (Schweiz) AG
Santhera Pharmaceuticals (Schweiz) AG
Liestal, CH
Other trademarks owned by Santhera Pharmaceuticals (Schweiz) AG
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Patrick J. Concannon
Patrick J. Concannon Locke Lord LLPPO BOX 1470Church Street StationNEW YORK, NY 10008-1470Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Active chemical ingredients for use in the manufacture of small molecule pharmaceuticals for treating neuromuscular and ophthalmological diseases; reagents for scientific and medical research for use in the research of small molecule pharmaceuticals and research of the treatment of neuromuscular and ophthalmological diseases; all of the foregoing excluding cleaning agents for use in laboratories and industries | SECTION 8 - CANCELLED | — |
| 005 | Chemical preparations for the treatment of neuromuscular and ophthalmological diseases; Pharmaceutical preparations for the treatment of central nervous system-related conditions, neurological and muscular diseases, neuro-muscular diseases, muscular dystrophies, ataxias, amyotrophia, atrophy, ophthalmological diseases; muscle wasting, cardiomyopathies, optic nerve degradation, neurological indications, memory loss, Lou Gehrig's disease, Parkinson's disease, Huntington's disease, spinal muscular atrophies, polyneuropathies, fibromyalgia, mononeuropathies, neuromuscular junction disorders, myotonia and myopathies; reagents for medical use in connection with the aforementioned diseases | SECTION 8 - CANCELLED | — |
| 042 | Medical research; science research; medical and scientific research, namely conducting clinical trials; computer programming for others for medical and science research purposes; scientific research for testing cell cultures and developing cellular test systems for evaluating new drugs and antibodies; developing test systems for detecting pharmacologically active compounds; animal model testing and research for neuro-muscular and ophthalmological diseases | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Santhera Pharmaceuticals (Schweiz) AG
- Other trademarks owned by Santhera Pharmaceuticals (Schweiz) AG
- Other trademarks owned by Santhera Pharmaceuticals (Schweiz) AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named OXITRAN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 5, 2016 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 26, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 1, 2010 | CORV | REVIEW OF CORRESPONDENCE COMPLETE | — |
| Jul 1, 2010 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 19, 2010 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 19, 2010 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 13, 2010 | PAPER RECEIVED | — | |
| Dec 29, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 8, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 23, 2009 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Nov 23, 2009 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Nov 23, 2009 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Sep 30, 2009 | PAPER RECEIVED | — | |
| Apr 9, 2008 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Jan 8, 2008 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Dec 11, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 21, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Nov 2, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 2, 2007 | ALIE | ASSIGNED TO LIE | — |
| Oct 1, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 1, 2007 | DMCC | DATA MODIFICATION COMPLETED | — |
| Sep 29, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 28, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 28, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 11, 2007 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2007 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 7, 2007 | NWAP | NEW APPLICATION ENTERED | — |